Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations by Lu, Shun, MD, Fang, Jian, MD, Li, Xingya, MD, Cao, Lejie, MD, Zhou, Jianying, MD, Guo, Qisen, MD, Liang, Zongan, MD, Cheng, Ying, MD, Jiang, Liyan, MD, Yang, Nong, MD, Han, Zhigang, MD, Shi, Jianhua, MD, Chen, Yuan, MD, Xu, Hua, MD, Zhang, Helong, MD, Chen, Gongyan, MD, Ma, Rui, MD, Sun, Sanyuan, MD, Fan, Yun, MD, Fan, Songhua, MD, Yu, Jie, MD, Lu, Puhan, PhD, Luo, Xian, MS, Su, Weiguo, PhD

Get full text

Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors by Dong, Xiaorong, MD, PhD, Li, Xingya, MD, Chen, Jianhua, MD, Ma, Shenglin, MD, Mu, Deguang, MD, Hu, Jie, MD, PhD, Lu, Shun, MD

Get full text

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibit... by Lu, Shun, Prof, Wu, Lin, Prof, Jian, Hong, MD, Chen, Ying, Prof, Wang, Qiming, MD, Fang, Jian, Prof, Wang, Ziping, MD, Hu, Yanping, Prof, Sun, Meili, MD, Han, Liang, MD, Miao, Liyun, Prof, Ding, Cuimin, MD, Cui, Jiuwei, Prof, Li, Baolan, Prof, Pan, Yueyin, Prof, Li, Xingya, MD, Ye, Feng, MD, Liu, Anwen, Prof, Wang, Ke, MD, Cang, Shundong, MD, Zhou, Hui, MD, Sun, Xing, MD, Ferry, David, MD, Lin, Yong, MD, Wang, Shuyan, MD, Zhang, Wen, MD, Zhang, Chengli, MD

Get full text

A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer by Geng, Di, Guo, Qianqian, Huang, Siyuan, Zhang, Huixian, Guo, Sanxing, Li, Xingya

Get full text

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Zhou, Zhiwei, Prof, Li, Jie, Prof, Bai, Chunmei, Prof, Chi, Yihebali, Prof, Li, Zhiping, Prof, Xu, Nong, Prof, Li, Enxiao, Prof, Liu, Tianshu, Prof, Bai, Yuxian, Prof, Yuan, Ying, Prof, Li, Xingya, Prof, Wang, Xiuwen, Prof, Chen, Jia, Prof, Ying, Jieer, Prof, Yu, Xianjun, Prof, Qin, Shukui, Prof, Yuan, Xianglin, Prof, Zhang, Tao, Prof, Deng, Yanhong, Prof, Xiu, Dianrong, Prof, Cheng, Ying, Prof, Tao, Min, Prof, Jia, Ru, MD, Wang, Wei, MD, Li, Jing, MD, Fan, Songhua, MD, Peng, Mengye, PhD, Su, Weiguo, PhD

Get full text

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, plac... by Wang, Jie, Prof, Zhou, Caicun, Prof, Yao, Wenxiu, Prof, Wang, Qiming, Prof, Min, Xuhong, BS, Chen, Gongyan, Prof, Xu, Xingxiang, Prof, Li, Xingya, Prof, Xu, Fei, Prof, Fang, Yong, Prof, Yang, Runxiang, Prof, Yu, Guohua, Prof, Gong, Youling, Prof, Zhao, Jun, Prof, Fan, Yun, Prof, Liu, Quan, Prof, Cao, Lejie, Prof, Yao, Yu, Prof, Liu, Yunpeng, Prof, Li, Xiaoling, Prof, Wu, Jingxun, Prof, He, Zhiyong, Prof, Lu, Kaihua, Prof, Jiang, Liyan, Prof, Hu, Chengping, Prof, Zhao, Wenhua, MD, Zhang, Ben, Ms, Shi, Wei, MD, Zhang, Xiaojing, MD, Cheng, Ying, Prof

Get full text